GSK sells rabies and ticks vaccines for nearly €1bn

The Aquafresh and Panadol drugs business GSK has sold two of its travel vaccines for up to €955 million, the company has announced.

GSK sells rabies and ticks vaccines for nearly €1bn

The Aquafresh and Panadol drugs business GSK has sold two of its travel vaccines for up to €955 million, the company has announced.

GSK said it will receive an upfront payment of €301m with the rest depending on certain sales targets being hit.

You have reached your article limit. Already a subscriber? Sign in

Unlimited access starts here.

Try from only €0.25 a day.

Cancel anytime

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited